Literature DB >> 8043011

Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3'-azido-2',3'-dideoxythymidine.

C Perigaud1, A M Aubertin, S Benzaria, H Pelicano, J L Girardet, G Maury, G Gosselin, A Kirn, J L Imbach.   

Abstract

It is shown that ddA bis(SATE)phosphotriester is one of the most potent anti-HIV agents in cell culture. Compared with the parent nucleoside, ddA, an increase of 3 orders of magnitude was observed in the EC50, which makes this compound as active as AZT. This can be tentatively explained if one considers that direct ddAMP intracellular delivery shunts the well established ddA/ddI metabolism pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043011     DOI: 10.1016/0006-2952(94)90217-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages.

Authors:  S Aquaro; O Wedgwood; C Yarnold; D Cahard; R Pathinara; C McGuigan; R Calio'; E de Clercq; J Balzarini; C F Perno
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.

Authors:  Kyla M Smith; Amy M L Ng; Sylvia Y M Yao; Kathy A Labedz; Edward E Knaus; Leonard I Wiebe; Carol E Cass; Stephen A Baldwin; Xing-Zhen Chen; Edward Karpinski; James D Young
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

3.  Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.

Authors:  T Shirasaka; S Chokekijchai; A Yamada; G Gosselin; J L Imbach; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.